Atlas Trials

Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections.

Clinical trial NCT04065971 · RECRUITING

Trial details

NCT number
NCT04065971
Sponsor
Labo'Life
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Herpes Simplex
Start date
2020-03-10
Primary completion
2027-03-31
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.